Description

A person who is taking a beta-adrenergic blocking agent and who develops anaphylaxis may develop a number of complications.


 

Factors affecting the effect of the beta-adrenergic blocking agent:

(1) selectivity of the beta-adrenergic blocking agent

(2) amount of beta-adrenergic blockade in effect at the time of anaphylaxis

(3) severity of anaphylaxis

 

Effects of nonspecific beta-blockade in a person with anaphylaxis:

(1) prolonged hypotension with bradycardia and intravascular volume depletion

(2) increased airway resistance

(3) decreased response to administered epinephrine, resulting in a muted response to the initial doses and the need for higher doses with an increased risk of epinephrine-related toxicity

 

Ellis and Day recommend the administration of glucagon IV at a dose of 5 to 15 micrograms per minute. Glucagon exerts an inotropic, chronotropic and vasoactive effect that does not require the blocker beta-adrenergic receptors.

 

The intravascular volume depletion may respond to fluid resuscitation.

 


To read more or access our algorithms and calculators, please log in or register.